Position in ZYME
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,000,440
+$55,861 QoQ
Shares Held
76,528
-1.5% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 202 holders
Holding Since
Jun 2023
9 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ZYME Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $9,184,405,765 across 177 Biotechnology names. ZYME ranks #114 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,771,839 | $1,728,352,485 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,347,253 | $1,662,680,977 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,862,503 | $496,766,798 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,040,250 | $491,639,040 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,488,394 | $278,746,426 | |
| 6 | INSM |
INSMED Inc
|
2,273,222 | $242,370,927 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
752,044 | $237,713,585 | |
| 8 | ARGX |
Argenx SE
|
224,930 | $208,683,303 |
All Filings in ZYME
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,000,440 | 76,528 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,944,579 | 77,659 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,553,126 | 58,987 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $577,661 | 33,821 | Shares | Defined | 2025-11-13 | |
| 2025-03-31 | $383,024 | 32,160 | Shares | Defined | 2025-05-13 | |
| 2024-03-31 | $1,204,096 | 114,458 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $459,050 | 44,182 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $271,915 | 42,889 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $217,105 | 25,128 | Shares | Defined | 2023-08-11 | |
| No filing history on record for this holder in this stock. | ||||||